Arax Advisory Partners’s Adverum Biotechnologies ADVM Stock Holding History

Arax Advisory Partners’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19	Closed	-$86	–	4082
2025 Q3	$86	Buy	+19	New	+$56	﹤0.01%	3505

Arax Advisory Partners's ADVM Position: Q4 2025 in Review

Arax Advisory Partners sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 19 shares — an estimated $86 sold.

Arax Advisory Partners first reported a position in ADVM in Q3 2025 and held it in 1 quarter. The position peaked at $86 in Q3 2025. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

Arax Advisory Partners reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 19 Adverum Biotechnologies shares in Q4 2025, an estimated $86.
Arax Advisory Partners first reported a position in Adverum Biotechnologies in Q3 2025 and held it in 1 quarter.
Arax Advisory Partners's Adverum Biotechnologies position peaked at $86 in Q3 2025.
0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.